Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...
The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a ...
Discover why Johnson & Johnson is a top stock pick for income investors in 2025 with strong sales growth and promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback